Search Results - "van Treijen, Mark J. C."
-
1
Head and Neck Paraganglioma (HNPGL) Registry: A study protocol for prospective data collection in patients with Head and Neck Paragangliomas
Published in PloS one (25-07-2024)“…There is a lack of comprehensive and uniform data on head and neck paragangliomas (HNPGLs), and research is challenging due to its rarity and the involvement…”
Get full text
Journal Article -
2
Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study
Published in European journal of hybrid imaging (09-12-2021)“…Background Early [ 68 Ga]Ga-DOTA-TOC PET/CT imaging after peptide receptor radionuclide therapy (PRRT) in neuroendocrine neoplasm patients is often used as a…”
Get full text
Journal Article -
3
The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([ 68 Ga]Ga-DOTATOC PET/CT) Compared with Magnetic Resonance Imaging of the Head and Neck Region in Paraganglioma Patients: A Pilot Study
Published in Cancers (28-02-2024)“…The Dutch guideline for patients suspected of head and neck paragangliomas (HNPGLs) recommends magnetic resonance imaging (MRI) and/or computed tomography (CT)…”
Get full text
Journal Article -
4
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study
Published in The lancet oncology (01-04-2020)“…In patients with metastatic neuroendocrine neoplasms, the liver is the most commonly affected organ and a crucial factor for prognosis and survival. Peptide…”
Get full text
Journal Article -
5
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression
Published in The journal of clinical endocrinology and metabolism (01-12-2021)“…Duodenopancreatic neuroendocrine tumors (dpNETs) frequently occur in patients with multiple endocrine neoplasia type 1 (MEN1), and metastatic dpNET is the…”
Get full text
Journal Article -
6
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression
Published in The journal of clinical endocrinology and metabolism (01-12-2023)“…Abstract Purpose Patients with multiple endocrine neoplasia type 1 (MEN1) are predisposed to develop duodenopancreatic neuroendocrine tumors (dpNETs), and…”
Get full text
Journal Article -
7
Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group
Published in The journal of clinical endocrinology and metabolism (01-12-2021)“…Nonfunctioning pancreatic neuroendocrine tumors (NF-pNETs) are highly prevalent and constitute an important cause of mortality in patients with multiple…”
Get full text
Journal Article -
8
Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
Published in Frontiers in endocrinology (Lausanne) (04-12-2018)“…Available neuroendocrine biomarkers are considered to have insufficient accuracy to discriminate patients with gastro-entero-pancreatic neuroendocrine tumors…”
Get full text
Journal Article -
9
FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels
Published in European journal of endocrinology (01-07-2022)“…Objective To evaluate the usefulness of [18F]fluorodeoxyglucose (FDG) positron emissive tomography (PET)/CT in patients with low detectable thyroglobulin…”
Get full text
Journal Article -
10
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
Published in Endocrine Connections (01-10-2022)“…Objective Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at…”
Get full text
Journal Article -
11
Blood Molecular Genomic Analysis Predicts the Disease Course of Gastroenteropancreatic Neuroendocrine Tumor Patients: A Validation Study of the Predictive Value of the NETest
Published in Neuroendocrinology (01-06-2021)“…Reliable prediction of disease status is a major challenge in managing gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The aim of the study was to…”
Get more information
Journal Article -
12
Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1
Published in The American journal of surgical pathology (01-02-2022)“…Patients with multiple endocrine neoplasia 1 syndrome (MEN1) often develop multifocal duodenopancreatic neuroendocrine tumors (dpNETs). Nonfunctional…”
Get full text
Journal Article -
13
Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base
Published in Journal of the Endocrine Society (01-09-2018)“…Abstract In multiple endocrine neoplasia type 1 (MEN1), nonfunctional pancreatic neuroendocrine tumors (NF-pNETs) are the most frequently diagnosed NETs and a…”
Get full text
Journal Article -
14
Possible pitfalls in the workup of ectopic ACTH secretion illustrated by four rare cases
Published in BMJ case reports (21-11-2019)“…In this case report, we highlight four different cases of ectopic adrenocorticotropic hormone (ACTH) secretion with different pitfalls in the diagnostic…”
Get full text
Journal Article -
15
Head and Neck Paraganglioma
Published in PloS one (25-07-2024)“…Introduction There is a lack of comprehensive and uniform data on head and neck paragangliomas (HNPGLs), and research is challenging due to its rarity and the…”
Get full text
Journal Article -
16
Hypoglycaemia with low insulin levels: what insulin tests do not measure
Published in Nederlands tijdschrift voor geneeskunde (2013)“…Insulin can be measured by immunochemical methods using polyclonal or monoclonal antibodies. Monoclonal antibodies are specific in the detection of pure human…”
Get more information
Journal Article